By Yusra Murad Top Stories Alexion Pharmaceuticals Inc. is set to acquire biotechnology company Achillion Pharmaceuticals Inc. in a deal originally valued at $930 million, giving Alexion’s rare disease portfolio a boost. The companies hope to finalize the purchase before mid-year 2020, as Alexion recovers from a scandal concerning its hallmark blood disorder drug […]
By Yusra Murad Top Stories Johnson & Johnson posted $20.73 billion in revenue in its third-quarter earnings report, edging past Wall Street’s projections, though it did not report litigation expenses as the drugmaker fends off thousands of lawsuits targeting its talc-based products and its alleged role in fueling the opioid epidemic. Revenue growth was […]
By Yusra Murad Top Stories A bankruptcy judge will delay until next month the upcoming trial in the massive opioid case brought by 24 states against Purdue Pharma LP, giving the drugmaker time to settle more than 2,600 lawsuits from across the country. The OxyContin-maker, state attorneys general and lawyers representing localities bringing the […]
By Yusra Murad Week in Review Trump administration The Trump administration released 800 pages of revised regulations for the existing anti-kickback statute and Stark law, setting off what is expected to be a months-long rule-making process. The changes are meant to encourage care coordination among providers, and promote value-based arrangements to improve patient care. A […]
By Yusra Murad Top Stories Purdue Pharma LP will appear in federal bankruptcy court today to request that pending litigation brought by state attorneys general be suspended until the drugmaker can bring down its legal costs and get more local governments to back its proposed settlement. At least 24 states currently oppose the deal […]
By Yusra Murad Top Stories Purdue Pharma LP’s plan to strike a deal with dozens of states and localities bringing opioid-related lawsuits is contingent on the drugmaker first resolving all Justice Department probes, according to a court filing that details publicly, for the first time, the OxyContin-maker’s plan to handle all ongoing opioid litigation. […]
By Yusra Murad Top Stories Arizona is weighing whether to back out of a federal opioid settlement with Purdue Pharma LP, as the state attorney general argued in a court filing that the OxyContin-maker sought to undermine “material terms” of the deal by requesting current lawsuits be halted while the company completes bankruptcy proceedings. […]
By Yusra Murad Top Stories Though the Justice Department is arguing in court that the Affordable Care Act is unconstitutional, if the federal appeals court issues a decision to invalidate the health law, the Trump administration plans to request a stay of the ruling, according to current and former administration officials. The administration may […]
By Yusra Murad Week in Review Electronic cigarettes The number of vaping-related illnesses reported to the Centers for Disease Control and Prevention grew by 275 last week, sending the total number of cases to 1,080 across 48 states and the Virgin Islands, as the death toll rose to 19. Sales growth for electronic cigarettes slowed […]
By Yusra Murad Top Stories The number of vaping-related illnesses reported to the Centers for Disease Control and Prevention grew by 275 this week, sending the total number of cases to 1,080 across 48 states and the Virgin Islands, as the death toll rose to 19. Roughly 70 percent of patients affected by the […]
